Clinical trial
Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer
NCT02769832
Study timeline
Study start (actual)2016-08-29Date precision: day
Registry last updated2025-07-29
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Small Cell Lung Cancer (SCLC)unresolved
Interventions
Nab-paclitaxelDRUG
GemcitabineDRUG · verified · RxNorm: gemcitabine
Sponsors & collaborators
Muhammad Furqanlead sponsor
Celgene Corporationcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02769832 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.